Granules India Net Profit Jumps 39% to ₹182 Crore

Drugmaker Granules India reported a 39% year-on-year increase in consolidated net profit to ₹181.8 crore for the September quarter.

Revenue from operations rose 20% year-on-year to ₹1,559.9 crore, despite higher input and logistics costs due to West Asia tensions.

The company plans to invest ₹828 crore in R&D, manufacturing, and quality, and is addressing 11 observations from a recent US FDA inspection.